Investigation of Four Cases of Stevens–Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020
The American Journal of Tropical Medicine and Hygiene · 2023
DOI: 10.4269/ajtmh.22-0625 ↗Kurz gefasst
Fachartikel in der Zeitschrift The American Journal of Tropical Medicine and Hygiene, 2023. Verfasst von Michelle A Chang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia. Hauptthemen laut MEDLINE: Antimalarials, Stevens-Johnson Syndrome, COVID-19, Malaria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
In 2018, a mass drug administration (MDA) campaign for malaria elimination was piloted in Haiti. The pilot treated 36,338 people with sulfadoxine-pyrimethamine (SP) and primaquine; no severe adverse events were detected. In 2020, another MDA campaign using the same medications was implemented to mitigate an upsurge in malaria cases during the COVID-19 pandemic. Four cases of Stevens–Johnson syndrome (SJS) were identified among the 42,249 people who took the medications. Three of these individuals required hospitalization; all survived. In addition to SP ingestion, an investigation of potential causes for increased SJS cases identified that all four cases had human leukocyte antigens A*29 and/or B*44:03, another known risk factor for SJS. Additionally, three of the four case individuals had antibodies to SARS-CoV-2, and the fourth may have been exposed around the same time. These findings raise the possibility that recent SARS-CoV-2 infection may have contributed to the increased risk for SJS associated with SP exposure during the 2020 campaign.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Malaria Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
- CDC Foundation, Atlanta, Georgia.
- Programme National de Contrôle de la Malaria, Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti.
- CDC-Haiti, Division of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Port-au-Prince, Haiti.
- Laboratoire National de la Santé Publique, Ministère de la Santé Publique et de la Population, Port-au-Prince, Haiti.
- Entomology Branch, Division of Parasitic Diseases and Malaria, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia.
Zitieren
APA
Chang, M. A., Fouché, B., LaFortune, W., Holmes, K., Rigodon, J., Juin, S., Marseille, S., Rogier, E., Green, M., Kheradmand, T., Moore, S. G., Gaul, D. A., Boncy, J., & Telfort, M. A. (2023). Investigation of Four Cases of Stevens–Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020. The American Journal of Tropical Medicine and Hygiene. https://doi.org/10.4269/ajtmh.22-0625
Vancouver
Chang MA, Fouché B, LaFortune W, Holmes K, Rigodon J, Juin S, et al. Investigation of Four Cases of Stevens–Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020. The American Journal of Tropical Medicine and Hygiene. 2023. doi:10.4269/ajtmh.22-0625
BibTeX
@article{Chang2023,
author = {Chang, Michelle A and Fouché, Bernadette and LaFortune, Willy and Holmes, Kathleen and Rigodon, Jonas and Juin, Stanley and Marseille, Samson and Rogier, Eric and Green, Michael and Kheradmand, Taba and Moore, Samuel G and Gaul, David A and Boncy, Jacques and Telfort, Marc-Aurele},
title = {Investigation of Four Cases of Stevens–Johnson Syndrome among Participants in a Mass Drug Administration Campaign with Sulfadoxine-Pyrimethamine and Primaquine in Haiti, 2020},
journal = {The American Journal of Tropical Medicine and Hygiene},
year = {2023},
doi = {10.4269/ajtmh.22-0625}
}
EUVIMED